Skip to the page

Data / Drug companies / Genus Lifesciences

Genus Lifesciences: 45 products in the FDA NDC directory, labeler code 64950

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Genus Lifesciences (labeler code 64950) lists 45 products in the FDA National Drug Code Directory, covering 23 finished drugs by generic name. By type: 45 prescription drugs. Its main marketing category is other unapproved drugs. The newest product started marketing on June 8, 2026.

The request: Watch Genus Lifesciences (FDA labeler code 64950): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
64950
Products in commercial distribution
45
Packages
81
Finished drugs by generic name
23
Prescription products
45
Over the counter products
0
Controlled substance products
Schedule II 7, Schedule III 1, Schedule IV 8, Schedule V 1
Flagged as original packager
42 of 42 products that carry the flag
Started marketing in the last 12 months
8
Products with a marketing end date set
5
Earliest marketing start
September 9, 2013
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Other unapproved drugs2044.4%
Generic drugs (ANDA)1840%
New drug applications (NDA)511.1%
Authorized generics (NDA)24.4%

Products by type

TypeProductsShare
Prescription drugs45100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet2760%
Solution1226.7%
Suspension12.2%
Cream12.2%
Powder, for solution12.2%
Tincture12.2%
Syrup12.2%
Solution/ drops12.2%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Phenazopyridine hydrochloride64950-551TabletOther unapproved drugsJune 8, 2026
Phenazopyridine hydrochloride64950-550TabletOther unapproved drugsJune 8, 2026
Opium64950-258TinctureOther unapproved drugsMay 15, 2026
Isosorbide Mononitrate64950-251TabletGeneric drugs (ANDA)April 9, 2026
Isosorbide Mononitrate64950-250TabletGeneric drugs (ANDA)April 9, 2026
Nystatin64950-372SuspensionGeneric drugs (ANDA)March 24, 2026
Halog64950-126CreamNew drug applications (NDA)January 13, 2026
Halog64950-127SolutionNew drug applications (NDA)November 17, 2025
Butalbital, Acetaminophen and Caffeine64950-290SolutionGeneric drugs (ANDA)July 1, 2025
Phenobarbital64950-578TabletOther unapproved drugsMarch 1, 2025
Phenobarbital64950-577TabletOther unapproved drugsMarch 1, 2025
Phenobarbital64950-576TabletOther unapproved drugsMarch 1, 2025
Phenobarbital64950-575TabletOther unapproved drugsMarch 1, 2025
Phenobarbital64950-574TabletOther unapproved drugsMarch 1, 2025
Phenobarbital64950-573TabletOther unapproved drugsMarch 1, 2025
Phenobarbital64950-572TabletOther unapproved drugsMarch 1, 2025
Phenobarbital64950-571TabletOther unapproved drugsMarch 1, 2025
RenThyroid64950-180TabletOther unapproved drugsMarch 1, 2025
RenThyroid64950-179TabletOther unapproved drugsMarch 1, 2025
RenThyroid64950-175TabletOther unapproved drugsMarch 1, 2025
RenThyroid64950-174TabletOther unapproved drugsMarch 1, 2025
RenThyroid64950-173TabletOther unapproved drugsMarch 1, 2025
RenThyroid64950-172TabletOther unapproved drugsMarch 1, 2025
RenThyroid64950-171TabletOther unapproved drugsMarch 1, 2025
RenThyroid64950-170TabletOther unapproved drugsMarch 1, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.